Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Page 10 of 18
Magazine
Big Hospitals vs. Big Pharma: Which industry is most to blame for soaring health care costs?
By
Trading Desk
April 8, 2021
Health
If a COVID-19 vaccine does turn out to be dangerous, who’s on the hook?
By
News Correspondent
April 7, 2021
Finance
BlackRock pledges to conduct a racial audit of its business
By
Editorial Team
April 6, 2021
Health
Why your wait time between COVID vaccine doses may be different than your neighbor’s
By
Trading Desk
April 3, 2021
Health
AstraZeneca COVID vaccine: German cities follow Canada in limiting rollout over clotting fears
By
Market Analyst
March 30, 2021
Health
As COVID cases spike, the EU introduces tough new vaccine export controls
By
David Meyer
and
Jeremy Kahn
March 24, 2021
International
‘A bitter failure’: Europe in turmoil over abrupt decision to halt the AstraZeneca COVID vaccine
By
Vivienne Walt
,
David Meyer
and
Bernhard Warner
March 16, 2021
Leadership
How Abbott, Merck, and more health care and biopharma companies took care during COVID
By
Claire Hastwell
and
Great Place To Work
March 12, 2021
Health
J&J’s COVID vaccine gets the all-clear in Europe—but an immediate rollout is unlikely
By
Investment Desk
March 11, 2021
Health
What most people get wrong about vaccine efficacy numbers
By
News Correspondent
March 5, 2021
Conferences
Why improved access and awareness are key to a more equitable vaccine rollout
By
Staff Writer
March 4, 2021
Health
Only one of the Big Four vaccine makers produced a COVID-19 winner. What happens next?
By
Senior Editor
March 3, 2021
Health
Biden set to announce vaccine manufacturing partnership between Merck and Johnson & Johnson
By
Staff Writer
March 2, 2021
Health
Biden officials warn Johnson & Johnson vaccine rollout may be slow
By
Trading Desk
March 1, 2021
Newsletters
‘HOLDING TO THE MOON’: Yes, the GameStop bulls are back
By
Tech Reporter
February 25, 2021
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Investment Desk
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
News Correspondent
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Blockchain Reporter